Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,519 articles

Articles by Daniel Marsh

Dow Plunges 406 Points as Oil Spike Revives Fed Rate Hike Fears
Markets

Dow Plunges 406 Points as Oil Spike Revives Fed Rate Hike Fears

The Dow Jones fell 406 points on Friday, dropping below 50,000 as oil and bond yields surged, reigniting fears of Federal Reserve rate hikes in 2026.

DIA SPY QQQ USO GLD XLE XLK XLF
Wall Street Drops as Oil Surge and AI Selloff Rattle Markets
Markets

Wall Street Drops as Oil Surge and AI Selloff Rattle Markets

U.S. stocks tumbled Friday amid a jump in oil prices and a broad selloff in AI and semiconductor shares, with the Dow closing down 406 points.

NVDA AMD INTC MSFT DXCM
BigBear.ai Shares Dip 5% as Defense AI Optimism Fades
Analysis

BigBear.ai Shares Dip 5% as Defense AI Optimism Fades

BigBear.ai shares dropped 5% to $4.16 after flat Q1 revenue and a wider loss, despite a 14% backlog increase driven by a $53 million classified contract.

BBAI PLTR AI
American Airlines Adds Football Seats, Faces Fuel Headwinds
Markets

American Airlines Adds Football Seats, Faces Fuel Headwinds

American Airlines is adding over 23,000 seats on more than 80 routes for football travel, but high fuel costs and debt continue to challenge its bottom line.

AAL DAL UAL
SoFi Stock Dips 2.6% on PrimaryBid Deal as Market Eyes Rate Headwinds
Markets

SoFi Stock Dips 2.6% on PrimaryBid Deal as Market Eyes Rate Headwinds

SoFi Technologies shares fell 2.6% after acquiring PrimaryBid's technology assets. The deal aims to boost retail IPO access but comes amid rising net charge-offs and unchanged 2026 guidance.

SOFI AFRM UPST
AI Rally Stalls as Surging Oil and Yields Pressure Nasdaq
Markets

AI Rally Stalls as Surging Oil and Yields Pressure Nasdaq

The Nasdaq slid 1.25% on Friday as rising oil prices and Treasury yields pressured stocks, erasing part of the week's AI rally. Nvidia, AMD, and Intel each fell over 4%.

NVDA AMD INTC SPY QQQ USO GLD TLT XLK
Dow Drops Below 50,000 as Surging Yields and Oil Jolt Markets
Markets

Dow Drops Below 50,000 as Surging Yields and Oil Jolt Markets

The Dow Jones Industrial Average fell below 50,000 on Friday as rising Treasury yields and oil prices near $109 sparked inflation fears, with chip stocks like Nvidia, AMD, and Intel leading the decline.

NVDA AMD INTC
Tesla Shares Decline on Stalled China FSD Approval After US-China Summit
Markets

Tesla Shares Decline on Stalled China FSD Approval After US-China Summit

Tesla shares dropped 3.7% after President Trump left Beijing without securing Chinese approval for its Full Self-Driving software, dampening investor sentiment.

TSLA
Micron Drops 5% as Samsung Strike Looms Over AI Memory Boom
Markets

Micron Drops 5% as Samsung Strike Looms Over AI Memory Boom

Micron stock slid 5.2% Friday on profit-taking and concerns over a possible Samsung strike that could disrupt AI memory supplies.

MU SSNLF AMD
Plug Power Shares Slip Amid Cash Burn Concerns Despite Revenue Growth
Markets

Plug Power Shares Slip Amid Cash Burn Concerns Despite Revenue Growth

Plug Power shares dipped 1.7% to $3.725 on Friday, as robust Q1 revenue growth of 22% to $163.5 million was overshadowed by a widened net loss of $245.3 million and operating cash burn of $150 million.

PLUG BLDP APD
Ford Stock Retreats After AI-Driven Energy Storage Rally Fades
Markets

Ford Stock Retreats After AI-Driven Energy Storage Rally Fades

Ford shares dropped 7% Friday after a rally sparked by its new energy storage unit. The business targets data centers but hasn't shipped yet.

F TSLA GM GLD
Biogen Completes Apellis Takeover, Gains Rare-Disease Pipeline
Markets

Biogen Completes Apellis Takeover, Gains Rare-Disease Pipeline

Biogen has completed its acquisition of Apellis Pharmaceuticals, delisting APLS shares. Biogen gains Syfovre and Empaveli, plus a kidney disease pipeline, with a CVR tied to Syfovre sales.

BIIB APLS